Xenon Pharmaceuticals Inc. (XENE)
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2017
- $311.0K
- Net income
- -$345.9M
- Total assets
- $633.2M
- Market cap
- $6.3B
- Operating margin
- -4974.3%
- Net margin
- -4612.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $7.5M
- Operating expenses
- $380.6M
- Operating income
- -$373.1M
- Income tax
- $1.0M
- Net income
- -$345.9M
- EPS (basic)
- $-4.36
- EPS (diluted)
- $-4.36
Balance sheet
- Total assets
- $633.2M
- Current assets
- $560.6M
- Total liabilities
- $51.4M
- Current liabilities
- $41.8M
- Shareholders’ equity
- $581.8M
Cash flow
- Operating cash flow
- -$279.1M
- Investing cash flow
- $218.0M
- Financing cash flow
- $117.1M
- Net cash flow
- $56.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.3B
- EPS (diluted)
- $-4.36
- Shares outstanding
- 99.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 5, 2014
Xenon Pharmaceuticals Inc. (XENE) Stock Price
- Reported a net loss of $345.9M in FY2017.
- Revenue declined 77% from FY2020 to FY2025.
- Trading 11% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Xenon Pharmaceuticals Inc..
Write a review
News about Xenon Pharmaceuticals Inc.
News & sentiment via Polygon.io
Xenon Pharmaceuticals Inc.: frequently asked questions
Is Xenon Pharmaceuticals Inc. an American company?
Xenon Pharmaceuticals Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Xenon Pharmaceuticals Inc. publicly traded?
Yes — Xenon Pharmaceuticals Inc. is a publicly traded company. Its stock trades under the ticker symbol XENE on the NASDAQ.
What does Xenon Pharmaceuticals Inc. do?
Xenon Pharmaceuticals Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
